Leo Berlinghieri
Analyst · Barclays
Thanks, Seth. Good morning, everyone, and thank you for joining us on the call today. I'll give a recap of the third quarter, as well as our outlook for the fourth quarter. Following me, Seth will go through the details of our quarterly results and guidance and then we'll open the call for your questions. Sales for the third quarter of 2012 were $141 million at the low end of our guidance and down 20% from last quarter. Sales to the semiconductor market were down 26% sequentially to $86 million and were 61% of revenue. As expected, sales to the solar market were down 74% to $2 million. Sales to all other markets were slightly up quarter-over-quarter and were $53 million. Third quarter non-GAAP net earnings were $8.4 million or $0.16 per share. GAAP net income was $2.6 million or $0.05 per share. Our balance of cash in short and long-term investments, net of debt, remain strong at $619 million and reflects the Q3 cash acquisition of Plasmart. Global economic conditions have remained unsettled and have impacted several of our markets. In the third quarter, demand in the semiconductor market continued to weaken. Several major device manufacturers have reduced their capital plans for the year and semiconductor tool OEMs have lowered their build plans and moved out deliveries accordingly. As a result, sales to the semiconductor OEMs were down 32% to $60 million, and sales to the semiconductor device manufacturers were $25 million, down 7% quarter-over-quarter. In spite of the current decline in semiconductor capital spending, the fundamentals for semiconductors in electronics remained sound. Historically, the industry advances work on next generation products in slower periods, and this time is no exception. Development of 3D devices, client [ph] geometries, advanced lithography, new materials and larger wafers continues. And we continue to work closely with both our OEM customers and device manufacturers as they focus on these opportunities. I'm pleased to report that in the third quarter, we once again had significant design wins for 450 millimeter tools, advanced etch applications and EUV lithography. We also achieved our first win for our advanced control products in the liquid delivery application as well as the first wins for our new Paragon on wafer plasma source with both U.S. and Asian OEMs. In the quarter, we also announced the acquisition of Plasmart, an innovative developer of radio frequency, RF, plasma generation and monitoring systems in Korea. Plasmart offers multiple growth opportunities in the semiconductor market as well as other advanced and growing markets. With its significant applications experience, Plasmart strengthens and augments our existing RF power capability. In addition, Plasmart provides MKS with greater access, not just to the Korean market but also to other key strategic customers throughout Asia. The additional technical expertise gained through the acquisition of Plasmart also enhances our ability to serve our customer base. While the decline in the semiconductor market has impacted Plasmart's near-term revenues as well, they are well-positioned to support their new customers' new product development requirements. They have numerous design wins in multiple ongoing development programs both with Korean and other Asian customers, and we anticipate that when the semiconductor market recovers, they will benefit as these designs go into volume production. In addition to increasing our share in the semiconductor market, our long-term growth strategy is to continue to strategically focus our business into other advanced markets where we can leverage our investments in R&D and operational infrastructure to a broader customer base. The other markets we target are selected because they have production processes that require high precision, utilize vacuum and gases and need a sophisticated level of instrumentation and control, similar to what is needed for the semiconductor market. These markets include thin film coatings, light emitting diodes, solar cells, drug development and production, medical, industrial and environmental, food and beverage and other critical applications. Looking first at the solar market, there continues to be an oversupply of solar modules, and government subsidies which provide incentives for solar installations have been reduced and, in some regions, eliminated completely. Demand continues to slow and orders have been lumpy. As anticipated, the third quarter sales to the solar market were $2.3 million, down 74% from the second quarter which, as I mentioned in our last call, had included $5 million of revenue from a large Chinese customer. Our solar business is now at the lowest level since 2009, and at this point, we are not seeing any rapid recovery. Despite current conditions, we do anticipate future growth for MKS in the solar market, and we continue to work with customers to address their development roadmap into identifying new opportunities with both tool OEMs and cell manufacturers, including a new win in the third quarter for our ozone products from a major cell producer in China. Despite the unsettled global economic conditions, our revenue to all other markets were $53 million, up slightly quarter-over-quarter. Similar to the semiconductor and solar markets, product development continues during a down period, and it's important to work with customers to gain design wins to drive future growth. Once again, I'd like to share some examples of how we leverage our technologies and infrastructure to successfully achieve new design wins in these additional markets. One of our targeted markets is biopharmaceutical and pharmaceutical manufacturing, which is complex and requires precise control of process. To achieve control of these complicated processes, the industry is increasingly adopting process analytical technologies, or PAT, to improve process control. The FDA defines PAT as a mechanism to design, analyze and control pharmaceutical manufacturing processes through the measurement of critical process parameters which affect critical quality attributes. Implementing PAT involves modeling the process, identifying which variables impact the process, designing experiments to validate assumptions and, finally, the ability to analyze in real time enormous amounts of data. Our multivariate analysis, as well as our design of experiment software, are the industry standards in complex data analysis. I am pleased to report that this quarter we have reached another milestone in the rollout of this software with a major global drug developer and manufacturer, as they have implemented the software at another of their U.S. facilities and have established plans for installation in multiple additional facilities in Europe in 2013. On a side note, analyzing large amounts of data is a requirement that goes far beyond industries like drug manufacturing. In fact, the same software also had a role in this year's Olympic Games. The testing laboratory supporting the games needed to rapidly analyze athlete test samples for banned substances. Like the drug industry, they relied on the same multivariate analysis software to quickly analyze the vast amounts of test results gathered to identify doping among the athletes. The need to analyze large and complex amounts of data is increasing in industry and in a host of other applications, and we are seeing more demand for our multivariate analysis software to rapidly convert raw data to actionable information. Moving to the medical electronics market where we supply power amplifiers for medical imaging -- to medical imaging OEMs. We have introduced our next-generation, high-field 3 tesla RF amplifier for MRI scanners. These amplifiers provide twice the power of typical MRI amplifiers, enabling improved diagnostic testing of soft tissue, such as the heart and the circulatory system. In the third quarter, we achieved a design win from one of the top OEMs in this market, and we are continuing our 3 tesla development programs with our other established MRI OEMs as well as with OEMs for emerging markets in Asia. In the environmental monitoring market. I've talked in the past about our gas analyzers, which are used to meet continuous emissions monitoring requirements for energy and power plants. Legislation is expanding the need for this monitoring into other industries with hazardous discharges. The manufacturing of some very low-tech products has the potential to emit very hazardous gases, and monitoring of these gases rely on the same high technology solutions we provide to the energy market. One of these applications is cement manufacturing, which has of the potential to release hydrochloric acid into the air. I'm pleased to report that in the third quarter, we received our first win from a U.S. OEM for emissions monitoring at a cement manufacturing facility, and we anticipate additional business in these applications in the future. These are just a few examples, but they illustrate how we leverage our technology, talent and infrastructure to gain businesses and grow revenue in new applications and other advanced markets. Over the past 8 years, we achieved a 15% compounded annual growth rate in these other advanced markets. Near term, however, the solar and LED equipment markets which helped drive this growth are depressed, and we are expected to remain down until excess capacity is absorbed. We anticipate that this will limit our ability to maintain this growth rate, at least organically, in the near term. The semiconductor downturn and the global economic weakness we've seen over the last few months are continuing. These are challenging times, but we have seen slow periods in the past and we have learned the importance of tightly managing the business as we go through them. I'd like to take a moment here and talk about how we are managing the business currently. We have curtailed noncritical spending and implemented a hiring freeze, including nonessential replacement personnel. We have reduced our workforce, scheduled mandatory time off and have made adjustments to variable compensation. However, we don't look at management as simply cutting cost. We are selective in choosing our spending reductions as we need to maintain our development programs and to continue to work with our customers to ensure that we get design wins, which will become volume business when the semiconductor industry and other key markets recover. Over the last 18 months, we've made deliberate investments to improve our quality and reliability, strengthen our management team globally, bolster IT [ph] capabilities and infrastructure and increase our technical capability closer to our customers. These are strategic efforts which we will continue as an investment in the future. We have also continued to look for opportunities to grow the business both organically and through acquisition. Semiconductor industry analysts in recent OEM reports suggest that the industry will decline further in the fourth quarter. Global economic conditions are expected to remain unsettled and business conditions will remain challenging. Given the current business levels, we anticipate that sales in the fourth quarter may range from $115 million to $135 million. And at these volumes, our non-GAAP net earnings could range from a net loss of $0.07 per share to net earnings of $0.06 per share. At this point, I'll turn the call over to Seth to discuss our results and expand on our guidance.